157 related articles for article (PubMed ID: 20394077)
1. CD5+ B cells from individuals with systemic lupus erythematosus express granzyme B.
Hagn M; Ebel V; Sontheimer K; Schwesinger E; Lunov O; Beyer T; Fabricius D; Barth TF; Viardot A; Stilgenbauer S; Hepp J; Scharffetter-Kochanek K; Simmet T; Jahrsdörfer B
Eur J Immunol; 2010 Jul; 40(7):2060-9. PubMed ID: 20394077
[TBL] [Abstract][Full Text] [Related]
2. IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation.
Garaud S; Le Dantec C; Jousse-Joulin S; Hanrotel-Saliou C; Saraux A; Mageed RA; Youinou P; Renaudineau Y
J Immunol; 2009 May; 182(9):5623-32. PubMed ID: 19380809
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of interleukin-21 receptor on peripheral B lymphocytes in systemic lupus erythematosus.
Mitoma H; Horiuchi T; Kimoto Y; Tsukamoto H; Uchino A; Tamimoto Y; Miyagi Y; Harada M
Int J Mol Med; 2005 Oct; 16(4):609-15. PubMed ID: 16142394
[TBL] [Abstract][Full Text] [Related]
5. Ganglioside GQ1b enhances anti-double-stranded DNA antibody and IgG production of PBMCs from patients with systemic lupus erythematosus.
Kanda N; Watanabe S
J Allergy Clin Immunol; 2000 Mar; 105(3):532-40. PubMed ID: 10719304
[TBL] [Abstract][Full Text] [Related]
6. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF
Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
[TBL] [Abstract][Full Text] [Related]
7. CD5+ B lymphocytes in systemic lupus erythematosus and rheumatoid arthritis.
Smith HR; Olson RR
J Rheumatol; 1990 Jun; 17(6):833-5. PubMed ID: 1696993
[TBL] [Abstract][Full Text] [Related]
8. Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus.
Huang YP; Perrin LH; Miescher PA; Zubler RH
J Immunol; 1988 Aug; 141(3):827-33. PubMed ID: 3135313
[TBL] [Abstract][Full Text] [Related]
9. High levels of TH2 cytokine gene expression in systemic lupus erythematosus.
Richaud-Patin Y; Alcocer-Varela J; Llorente L
Rev Invest Clin; 1995; 47(4):267-72. PubMed ID: 8525128
[TBL] [Abstract][Full Text] [Related]
10. Transgene-mediated hyper-expression of IL-5 inhibits autoimmune disease but increases the risk of B cell chronic lymphocytic leukemia in a model of murine lupus.
Wen X; Zhang D; Kikuchi Y; Jiang Y; Nakamura K; Xiu Y; Tsurui H; Takahashi K; Abe M; Ohtsuji M; Nishimura H; Takatsu K; Shirai T; Hirose S
Eur J Immunol; 2004 Oct; 34(10):2740-9. PubMed ID: 15368290
[TBL] [Abstract][Full Text] [Related]
11. The paradox of CD5-expressing B cells in systemic lupus erythematosus.
Youinou P; Renaudineau Y
Autoimmun Rev; 2007 Dec; 7(2):149-54. PubMed ID: 18035326
[TBL] [Abstract][Full Text] [Related]
12. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.
Papadimitraki ED; Choulaki C; Koutala E; Bertsias G; Tsatsanis C; Gergianaki I; Raptopoulou A; Kritikos HD; Mamalaki C; Sidiropoulos P; Boumpas DT
Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805
[TBL] [Abstract][Full Text] [Related]
13. Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with systemic lupus erythematosus.
Nagafuchi H; Suzuki N; Mizushima Y; Sakane T
J Immunol; 1993 Dec; 151(11):6525-34. PubMed ID: 8245483
[TBL] [Abstract][Full Text] [Related]
14. Increased peripheral blood B-cells expressing the CD5 molecules in association to autoantibodies in patients with lupus erythematosus and evidence to selectively down-modulate them.
Böhm I
Biomed Pharmacother; 2004 Jun; 58(5):338-43. PubMed ID: 15194170
[TBL] [Abstract][Full Text] [Related]
15. B cell hyperactivity is a function of T cell derived cytokines in systemic lupus erythematosus.
al-Janadi M; Raziuddin S
J Rheumatol; 1993 Nov; 20(11):1885-91. PubMed ID: 7508509
[TBL] [Abstract][Full Text] [Related]
16. High-density expression of CD95 on B cells and underrepresentation of the B-1 cell subset in human lupus.
Huck S; Jamin C; Youinou P; Zouali M
J Autoimmun; 1998 Oct; 11(5):449-55. PubMed ID: 9802928
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 21-induced granzyme B-expressing B cells infiltrate tumors and regulate T cells.
Lindner S; Dahlke K; Sontheimer K; Hagn M; Kaltenmeier C; Barth TF; Beyer T; Reister F; Fabricius D; Lotfi R; Lunov O; Nienhaus GU; Simmet T; Kreienberg R; Möller P; Schrezenmeier H; Jahrsdörfer B
Cancer Res; 2013 Apr; 73(8):2468-79. PubMed ID: 23384943
[TBL] [Abstract][Full Text] [Related]
18. High-affinity antibodies to ssDNA are produced by CD-B cells in systemic lupus erythematosus patients.
Casali P; Burastero SE; Balow JE; Notkins AL
J Immunol; 1989 Dec; 143(11):3476-83. PubMed ID: 2479680
[TBL] [Abstract][Full Text] [Related]
19. The V(lambda)-J(lambda) repertoire of patients with systemic lupus erythematosus manifests characteristics of the natural antibody repertoire.
Lee J; Cho YJ; Lipsky PE
Arthritis Rheum; 2004 Aug; 50(8):2604-14. PubMed ID: 15334475
[TBL] [Abstract][Full Text] [Related]
20. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus.
Wang H; Xu J; Ji X; Yang X; Sun K; Liu X; Shen Y
Cell Immunol; 2005 Jun; 235(2):117-21. PubMed ID: 16226734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
